ORIONS Money Stocks

[Gls3ms]

RLFTF trial drug gets double lung transplant patient with Covid off ventilator

https://www.google.com/amp/s/mobile.reuters.com/article/amp/idUSKBN24Y0OR

“In June the U.S. Food and Drug Administration granted fast-track designation to RLF-100 for treatment of respiratory distress in COVID-19.”


“It said a 54-year-old man who developed COVID-19 while being treated for rejection of a double lung transplant came off a ventilator within four days of treatment with RLF-100.

Similar results were subsequently seen in more than 15

patients treated under emergency use, the companies said.”

https://www.clinicaltrialsarena.com/news/neurorx-relief-aviptadil-data/


https://www.prnewswire.com/news-releases/fda-grants-expanded-access-protocol-to-rlf-100-aviptadil-for-respiratory-failure-in-covid-19-currently-in-development-by-neurorx-and-relief-therapeutics-under-fast-track-designation-301101816.html